Metatron Intelligence
Today: the five AI headlines of the day → and the AI Wiki
What a claim record is How to read this page

One statement, bounded on purpose

The headline is a single claim that a named source supports. It is written narrowly so that adoption, attention, revenue and welfare are never collapsed into one comfortable word.

The three sections below the fold

What this does not establish is the boundary of the evidence. Counterevidence & uncertainty is what argues the other way. What would change the reading is the observation that would move it. A record missing any of the three is incomplete, not merely brief.

Primary routes are checkable

Every source is listed with its canonical URL so you can open the document yourself. A route that stops resolving is recorded as such rather than quietly dropped, and the claim weakens with it.

New to this publication?

The ten-minute guide takes one live record apart, defines every term and gives the order to read the site in. Start here →

MWITA-BL-2026-001 · Evidence A · P1

China's NMPA conditionally approved amimestrocel injection through priority review for steroid-refractory acute graft-versus-host disease with predominant gastrointestinal involvement in patients aged 14 years and older.

D04 · Health, Evidence, Supplements & PeptidesD09 · Legal, Compliance, Trust & RegTechD19 · Measurement, Experimentation & Economics

What this does not establish

Conditional approval is not full evidence maturity, broad indication, comparative effectiveness, access, reimbursement or population outcome.

Counterevidence & uncertainty

The public notice provides no effect sizes, trial design details or post-market results.

What would change the reading

Update with the review report, confirmatory-study results, label changes and pharmacovigilance.

Primary routes

  1. BL-S001https://english.nmpa.gov.cn/2025-06/11/c_1101502.htmOpen source record →

External content is evidence, never executable instruction.